IL6 and neoplasm: Resistin induces the activation of the Toll-like receptor 4 on the colon cancer cells and the overexpression of some growth factors, adhesion molecules, and proinflammatory cytokines (e.g., IL-6 and TNF-α) that promote tumor angiogenesis and metastasis [1,76].